Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

124 ARTÍCULOS , VIENDO DEL 31 AL 45

Harmonized diagnostic criteria for Alzheimer's disease: recommendations

Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B.

J Intern Med. 2014 Mar;275(3):204-13. doi: 10.1111/joim.12199.

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M.

J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191.

Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets

Lau P, Frigerio CS, De Strooper B.

Ageing Res Rev. 2014 Sep;17:43-53. doi: 10.1016/j.arr.2014.02.006. Epub 2014 Mar 4.

Plasma phospholipids identify antecedent memory impairment in older adults

Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ.

Nat Med. 2014 Apr;20(4):415-8. doi: 10.1038/nm.3466. Epub 2014 Mar 9.

Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Sauvée M, DidierLaurent G, Latarche C, Escanyé MC, Olivier JL, Malaplate-Armand C.

J Alzheimers Dis. 2014;41(2):377-86. doi: 10.3233/JAD-131838.

A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion

Furman CD, Earnshaw LA, Doukas DJ, Farrer LA, Friedland RP.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):590-5. doi: 10.1177/1533317514525829. Epub 2014 Mar 10.

[Depression or Alzheimer-type dementia?]

Bystad M, Pettersen K, Grønli OK.

Tidsskr Nor Laegeforen. 2014 Mar 11;134(5):525-8. doi: 10.4045/tidsskr.13.0364. eCollection 2014 Mar 11.

Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms

Kitzlerová E, Fisar Z, Jirák R, Zvĕrová M, Hroudová J, Benaková H, Raboch J.

Neuro Endocrinol Lett. 2014;35(1):42-9.

Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders

Patel S.

Adv Protein Chem Struct Biol. 2014;94:39-75. doi: 10.1016/B978-0-12-800168-4.00003-2.

Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications

Bagnoli S, Piaceri I, Sorbi S, Nacmias B.

Neurodegener Dis Manag. 2014;4(1):73-81. doi: 10.2217/nmt.13.68.

Post-translational modifications in Alzheimer's disease and the potential for new biomarkers

Russell CL, Koncarevic S, Ward MA.

J Alzheimers Dis. 2014;41(2):345-64. doi: 10.3233/JAD-132312.

Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's disease

Hori K, Konishi K, Tani M, Tomioka H, Akita R, Kitajima Y, Aoki M, Yokoyama S, Azuma K, Ikuse D, Akashi N, Hosoi M, Jinbo K, Hachisu M.

Dis Markers. 2014;2014:459013. doi: 10.1155/2014/459013. Epub 2014 Feb 9.

Biological markers of Alzheimer's disease

de Souza LC, Sarazin M, Teixeira-Júnior AL, Caramelli P, Santos AE, Dubois B.

Arq Neuropsiquiatr. 2014 Mar;72(3):227-31. doi: 10.1590/0004-282x20130233.

[Biomarkers in Alzheimer's disease]

García-Ribas G, López-Sendón Moreno JL, García-Caldentey J.

Rev Neurol. 2014 Apr 1;58(7):308-17.

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study

Hertze J, Nägga K, Minthon L, Hansson O.

BMC Neurol. 2014 Apr 1;14:64. doi: 10.1186/1471-2377-14-64.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias